These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33164665)

  • 1. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.
    Pruskowski KA
    Surg Infect (Larchmt); 2021 Feb; 22(1):77-82. PubMed ID: 33164665
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial treatment in burn injury patients].
    Trupkovic T; Gille J; Fischer H; Kleinschmidt S
    Anaesthesist; 2012 Mar; 61(3):249-51, 254-6, 258. PubMed ID: 22430556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.
    Ortwine JK; Pogue JM; Faris J
    J Burn Care Res; 2015; 36(2):e72-84. PubMed ID: 25167375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.
    Steele AN; Grimsrud KN; Sen S; Palmieri TL; Greenhalgh DG; Tran NK
    J Burn Care Res; 2015; 36(3):e194-211. PubMed ID: 25942648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis.
    Fujii M; Karumai T; Yamamoto R; Kobayashi E; Ogawa K; Tounai M; Lipman J; Hayashi Y
    Expert Opin Drug Metab Toxicol; 2020 May; 16(5):415-430. PubMed ID: 32238005
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
    Blanchet B; Jullien V; Vinsonneau C; Tod M
    Clin Pharmacokinet; 2008; 47(10):635-54. PubMed ID: 18783295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in critically ill burn patients.
    Hidalgo F; Mas D; Rubio M; Garcia-Hierro P
    Med Intensiva; 2016 Apr; 40(3):179-85. PubMed ID: 27013315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated antimicrobial dosing recommendations for obese patients.
    Castro-Balado A; Varela-Rey I; Mejuto B; Mondelo-García C; Zarra-Ferro I; Rodríguez-Jato T; Fernández-Ferreiro A
    Antimicrob Agents Chemother; 2024 May; 68(5):e0171923. PubMed ID: 38526051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Selection and Use of Antimicrobials in Patients with Burn Injuries.
    Hill DM; Sinclair SE; Hickerson WL
    Clin Plast Surg; 2017 Jul; 44(3):521-534. PubMed ID: 28576241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Antimicrobial Agents for Burn Wound Care: History and Current Status.
    Cancio LC
    Surg Infect (Larchmt); 2021 Feb; 22(1):3-11. PubMed ID: 33124942
    [No Abstract]   [Full Text] [Related]  

  • 13. Profile of infections and antimicrobial treatment among burn-injury patients.
    Sakabe D; Del Fiol Fde S
    Am J Infect Control; 2016 Aug; 44(8):950-2. PubMed ID: 27324611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of antibiotics in burn patients.
    Weinbren MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):319-27. PubMed ID: 10511398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The basic principles of the antibiotic therapy of burn patients].
    Leseva M; Khadzhiĭski O; Grigorov G; Dimitrova A
    Khirurgiia (Sofiia); 1995; 48(3):8-11. PubMed ID: 8667589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics in patients with burns.
    Jaehde U; Sörgel F
    Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin population pharmacokinetics among paediatric burn patients.
    Sherwin CM; Wead S; Stockmann C; Healy D; Spigarelli MG; Neely A; Kagan R
    Burns; 2014 Mar; 40(2):311-8. PubMed ID: 23876785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical antimicrobials in pediatric burn wound management.
    Patel PP; Vasquez SA; Granick MS; Rhee ST
    J Craniofac Surg; 2008 Jul; 19(4):913-22. PubMed ID: 18650712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
    Machado AS; Oliveira MS; Sanches C; Silva Junior CVD; Gomez DS; Gemperli R; Santos SRCJ; Levin AS
    Clin Ther; 2017 Aug; 39(8):1649-1657.e3. PubMed ID: 28705450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.